Close

UDG Healthcare raises full-year earnings forecast

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Low-Carbon Inhalers Approved for COPD Treatment in the UK

According to AstraZeneca, the Medicines and Healthcare Products Regulatory...

Chinese Medtech Companies Reshape Healthcare by Innovation

The worldwide medtech spectrum is undergoing a phenomenal shift,...

The Benefits of Virtual GP Insurance: A Game Changer for Modern Healthcare

In today’s fast-paced world, accessing healthcare quickly and efficiently...

Vaxxas Secures U.S. Patent for HD-MAP Vaccine Technology

Vaxxas, a clinical-stage biotech firm has obtained a new...

UDG Healthcare Plc reported a 19 percent rise in adjusted operating profit and raised its full-year earnings forecast.
The company, which provides outsourced sales and marketing, drug distribution and packaging services to healthcare firms, said it expects adjusted earnings per share (EPS) growth of 7 percent to 9 percent at constant currency.
UDG Healthcare had earlier forecast growth of 5 percent to 8 percent for the year to Sept. 30, 2015.
Adjusted operating profit rose to 53.6 million euros ($60.9 million) for the six months ended March 31 from 45.0 million euros a year earlier.
Revenue rose 9 percent to 1.13 billion euros.

 

Latest stories

Related stories

Low-Carbon Inhalers Approved for COPD Treatment in the UK

According to AstraZeneca, the Medicines and Healthcare Products Regulatory...

Chinese Medtech Companies Reshape Healthcare by Innovation

The worldwide medtech spectrum is undergoing a phenomenal shift,...

The Benefits of Virtual GP Insurance: A Game Changer for Modern Healthcare

In today’s fast-paced world, accessing healthcare quickly and efficiently...

Vaxxas Secures U.S. Patent for HD-MAP Vaccine Technology

Vaxxas, a clinical-stage biotech firm has obtained a new...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back